Ischemia
Researchers' work from INSERM focuses on ischemia
Published in Blood Weekly, September 13th, 2007
"The aim of this study was to evaluate the role of the mitochondrial permeability transition pore (MPTP) in the protection achieved by post-conditioning of hearts submitted to hypothermic cardioplegia and ischemia. Isolated rat hearts (n = 30) underwent cold cardioplegia (4 degrees C, Celsior solution) and 8 hours of ischemia at 4 degrees C, followed by a 60-minute Langendorff reperfusion," scientists writing in the Journal of Heart and Lung Transplantation report.
"Hearts were randomly assigned to one of two groups: post-conditioning (post-C, consisting of episodes of 30-second ischemia and 30-second reperfusion at onset of reperfusion) or control (no...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-09-13)
More Articles from Blood Weekly
- Biomedicine
Unique Mouse Joins Battle Against Dengue Fever - Biomedicine
“M GO BLUE for Mott” Rally Scarves Benefit Children's Hospital - Liver Transplant
Inhaling Nitric Oxide Helps Liver Transplant Success - Vascular Disease
Renal Transplant Recipients’ Genetic Makeup Does Not Negatively Impact Fluvastatin Use - Acute Lymphoblastic Leukemia
Rituxan and Other Emerging Agents Will Find Success When Used in Combination With Existing Therapies for Treatment of Acute Lymphoblastic Leukemia - Acute Lymphocytic Leukemia
New FDA Orphan Drugs: Nitroimidazole PA-824, 3'-deoxyadenosine, Iobenguane I 131 - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
